There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Hepatocellular carcinoma (HCC) is highly prevalent and the third most common cause of
cancer-related death in Asia. In contrast to the West, the main etiology of HCC in many Asian …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in
Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 …

Abstract The Clinical Practice Manual for Hepatocellular Carcinoma was published based
on evidence confirmed by the Evidence-based Clinical Practice Guidelines for …

In the past 10 years, many guidelines for hepatocellular carcinoma (HCC) have been
published worldwide. To promote standard care for HCC, we systematically evaluated 17 …

Hepatocellular carcinoma (HCC) is responsible for approximately 600 000–700 000 deaths
worldwide. It is highly prevalent in the Asia–Pacific region and Africa, and is increasing in …

Abstract The “Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC),” the first
evidence-based guidelines for the treatment of HCC in Japan, were compiled by an expert …

The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised
by the Japan Society of Hepatology, according to the methodology of evidence‐based …

Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the second
leading cause of cancer-related mortality worldwide. This review is an updated version that …

Many guidelines for hepatocellular carcinoma (HCC) have been published and updated
globally. In contrast to other cancers, there is a range of treatment options for HCC involving …